BRAINTREE, Mass., March 9, 2012 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced today that it will host its annual investor and analyst day on Thursday, May 10th from 10:00 am to 12:30 pm at its corporate headquarters in Braintree, Massachusetts.
The agenda for the meeting includes updates on the following:
Blood Management Solutions / IMPACT® Selling
Programs For Continued Growth in Emerging Markets
R&D Update Including Automated Whole Blood Collection Advances
Fiscal 2013 Guidance
The meeting is open to analysts, shareholders, and others in the investment community by invitation. Invitations will follow shortly and attendees must register by April 26th. Online registration will be utilized and instructions for registration will accompany invitations.
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing innovative blood management solutions for our customers. Together, our devices and consumables, information technology platforms, and consulting services deliver a suite of business solutions to help our customers improve clinical outcomes and reduce the cost of healthcare for blood collectors, hospitals, and patients around the world. Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit our web site at http://www.haemonetics.com.